These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 135909)

  • 21. [Clinical treatment results of treating androgenization symptoms in women with preparation Diane-35].
    Marianowski L; Cyganek A; Grzechocińska B
    Wiad Lek; 1994 Oct; 47(19-20):745-6. PubMed ID: 7483620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of medium severe androgenizing symptoms in women].
    Turina D; Keller PJ; Floersheim Y
    Gynakol Rundsch; 1980 Jun; 20 Suppl 1():81-3. PubMed ID: 6452320
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of acne, hirsutism and alopecia, by cyproterone acetate and ethinyl estradiol].
    Neale C; Krebs D; Bettendorf G
    Acta Endocrinol Suppl (Copenh); 1971; 152():13. PubMed ID: 4251532
    [No Abstract]   [Full Text] [Related]  

  • 24. [Anti-androgen treatments in gynecology].
    Schindler AE
    Dtsch Med Wochenschr; 1977 May; 102(20):763-5. PubMed ID: 67924
    [No Abstract]   [Full Text] [Related]  

  • 25. [Hirsutism treated with cyproterone acetate and ethinyl estradiol. Influence on androgens in the serum and urine and on urinary cortisol].
    Nielsen DR; Larsen J; Pedersen IM; Starup J
    Ugeskr Laeger; 1985 Aug; 147(33):2589-93. PubMed ID: 2933857
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of acne and seborrhea using antiandrogens].
    Keller PJ; Fetz A; Schär A; Floersheim Y
    Schweiz Med Wochenschr; 1978 Oct; 108(42):1640-2. PubMed ID: 151916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyproterone acetate/ethinyl estradiol for acne and hirsutism: time to revise prescribing policy.
    Franks S; Layton A; Glasier A
    Hum Reprod; 2008 Feb; 23(2):231-2. PubMed ID: 18083746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Use of cyproterone acetate in the treatment of acne].
    Piquero Martín J; Acosta H
    Med Cutan Ibero Lat Am; 1982; 10(4):261-6. PubMed ID: 6222232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A cyproterone acetate-ethinyl estradiol combination in the treatment of acne. Data of a survey of gynecologists].
    Vignini M; Pelfini C; Montanari L
    Minerva Ginecol; 1988 Feb; 40(2):125-32. PubMed ID: 2969466
    [No Abstract]   [Full Text] [Related]  

  • 30. Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase III trial.
    Plewig G; Cunliffe WJ; Binder N; Höschen K
    Contraception; 2009 Jul; 80(1):25-33. PubMed ID: 19501212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical results of antiandrogen therapy using cyproterone acetate in virilization].
    Engel MF; Schmidt-Elmendorff H
    Arch Gynecol; 1979 Jul; 228(1-4):574-5. PubMed ID: 158344
    [No Abstract]   [Full Text] [Related]  

  • 32. Acne vulgaris. The past. The present and the future.
    Cunliffe WJ
    Acta Derm Venereol Suppl (Stockh); 1985; 120():34-8. PubMed ID: 2939675
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of the combination of cyproterone acetate and conjugated estrogens on hirsutism, alopecia and acne].
    Eschiletti MA; Goldim JR; Bakos L; Gross JL
    AMB Rev Assoc Med Bras; 1986; 32(3-4):61-4. PubMed ID: 3024241
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical findings with a low-dosed antiandrogene (cyproteronacetate) and aethinyloestradiol women with virilising symptoms (author's transl)].
    Schmidt-Elmendorff H; Steyer M
    Geburtshilfe Frauenheilkd; 1977 Apr; 37(4):297-303. PubMed ID: 140094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new association of ethinylestradiol (0.035 mg) cyproterone acetate (2 mg) in the therapy of polycystic ovary syndrome.
    Falsetti L; Dordoni D; Gastaldi C; Gastaldi A
    Acta Eur Fertil; 1986; 17(1):19-25. PubMed ID: 2941960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Dermatologic therapy unit anti-androgens].
    Nolting S
    Fortschr Med; 1977 Mar; 95(12):825-8. PubMed ID: 140141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Proceedings: Antiandrogens].
    Hammerstein J
    Arch Gynakol; 1973 Sep; 214(1):243-7. PubMed ID: 4130934
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effects of a chlormadinone acetate-containing ovulation inhibitor on androgenization pictures and liver and lipid metabolism in young females].
    Cirkel U; Belkien L; Hanker JP; Schweppe KW; Schneider HP
    Geburtshilfe Frauenheilkd; 1986 Jul; 46(7):439-43. PubMed ID: 2428694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The antiandrogens. When and how they should be used.
    Sawaya ME; Hordinsky MK
    Dermatol Clin; 1993 Jan; 11(1):65-72. PubMed ID: 8435919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Dermatologic indications for anti-androgenic treatment].
    Zaun H; Ludwig E
    Z Hautkr; 1978 Nov; 53(21):759-65. PubMed ID: 82309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.